Annual EPS
-$2.63
-$0.33-14.35%
31 December 2023
Summary:
Monte Rosa Therapeutics annual earnings per share is currently -$2.63, with the most recent change of -$0.33 (-14.35%) on 31 December 2023. During the last 3 years, it has fallen by -$0.98 (-59.35%). GLUE annual EPS is now -278.69% below its all-time high of -$0.69, reached on 31 December 2019.GLUE EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.29
+$0.14+32.56%
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly earnings per share is currently -$0.29, with the most recent change of +$0.14 (+32.56%) on 30 September 2024. Over the past year, it has increased by +$0.41 (+58.57%). GLUE quarterly EPS is now -46.54% below its all-time high of -$0.20, reached on 31 March 2020.GLUE Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$1.83
+$0.41+18.30%
30 September 2024
Summary:
Monte Rosa Therapeutics TTM earnings per share is currently -$1.83, with the most recent change of +$0.41 (+18.30%) on 30 September 2024. Over the past year, it has increased by +$0.86 (+31.97%). GLUE TTM EPS is now -824.71% below its all-time high of -$0.20, reached on 31 March 2020.GLUE TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.3% | +58.6% | +32.0% |
| 3 y3 years | -59.4% | +32.6% | +65.2% |
| 5 y5 years | - | - | - |
GLUE EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -59.4% | +11.2% | at high | +59.1% | at high | +65.2% |
| 5 y | 5 years | -278.7% | +11.2% | -46.5% | +92.0% | -824.7% | +65.2% |
| alltime | all time | -278.7% | +11.2% | -46.5% | +92.0% | -824.7% | +65.2% |
Monte Rosa Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$0.29(-32.6%) | -$1.83(-18.3%) |
| June 2024 | - | -$0.43(-18.9%) | -$2.24(-11.1%) |
| Mar 2024 | - | -$0.53(-8.6%) | -$2.52(-4.5%) |
| Dec 2023 | -$2.63(+14.3%) | -$0.58(-17.1%) | -$2.64(-1.9%) |
| Sept 2023 | - | -$0.70(-1.4%) | -$2.69(+4.7%) |
| June 2023 | - | -$0.71(+9.2%) | -$2.57(+5.8%) |
| Mar 2023 | - | -$0.65(+3.2%) | -$2.43(+6.1%) |
| Dec 2022 | -$2.30 | -$0.63(+8.6%) | -$2.29(+5.8%) |
| Sept 2022 | - | -$0.58(+1.8%) | -$2.16(+7.4%) |
| June 2022 | - | -$0.57(+11.8%) | -$2.01(-60.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$0.51(+1.3%) | -$5.07(+4.6%) |
| Dec 2021 | -$2.96(+79.3%) | -$0.50(+17.1%) | -$4.85(-7.6%) |
| Sept 2021 | - | -$0.43(-88.2%) | -$5.25(+2.5%) |
| June 2021 | - | -$3.63(+1157.8%) | -$5.12(+194.3%) |
| Mar 2021 | - | -$0.29(-68.1%) | -$1.74(+5.5%) |
| Dec 2020 | -$1.65(+137.7%) | -$0.90(+199.7%) | -$1.65(+121.1%) |
| Sept 2020 | - | -$0.30(+22.2%) | -$0.75(+67.8%) |
| June 2020 | - | -$0.25(+24.7%) | -$0.44(+124.7%) |
| Mar 2020 | - | -$0.20 | -$0.20 |
| Dec 2019 | -$0.69 | - | - |
FAQ
- What is Monte Rosa Therapeutics annual earnings per share?
- What is the all time high annual EPS for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual EPS year-on-year change?
- What is Monte Rosa Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly EPS year-on-year change?
- What is Monte Rosa Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics TTM EPS year-on-year change?
What is Monte Rosa Therapeutics annual earnings per share?
The current annual EPS of GLUE is -$2.63
What is the all time high annual EPS for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual earnings per share is -$0.69
What is Monte Rosa Therapeutics annual EPS year-on-year change?
Over the past year, GLUE annual earnings per share has changed by -$0.33 (-14.35%)
What is Monte Rosa Therapeutics quarterly earnings per share?
The current quarterly EPS of GLUE is -$0.29
What is the all time high quarterly EPS for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly earnings per share is -$0.20
What is Monte Rosa Therapeutics quarterly EPS year-on-year change?
Over the past year, GLUE quarterly earnings per share has changed by +$0.41 (+58.57%)
What is Monte Rosa Therapeutics TTM earnings per share?
The current TTM EPS of GLUE is -$1.83
What is the all time high TTM EPS for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high TTM earnings per share is -$0.20
What is Monte Rosa Therapeutics TTM EPS year-on-year change?
Over the past year, GLUE TTM earnings per share has changed by +$0.86 (+31.97%)